Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
March 8, 2005
Pituitary abscess in a patient with painless thyroiditis
Akira Matsuno, Yoshio Ogino, Haruko Katayama, et al.
Expert Opinion on Therapeutic Patents
|
September 12, 2009
Modulation of neuropeptide Y receptors for the treatment of obesity
Nagaaki Sato, Yoshio Ogino, Satoshi Mashiko, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
October 15, 2011
[Trigger point therapy for myofascial pain in cancer patients (first report)-analysis results of special use-results surveillance by Neovitacain® injection-]
Asami Yamaguchi, Yoshio Ogino, Chie Iwakoshi, et al.
Case Reports in Obstetrics and Gynecology
|
September 4, 2014
An Unusual Case of Fulminant Type 1 Diabetes during the Second Trimester of Pregnancy
Tomohiro Okuda, Sadao Yamashita, Yoshio Ogino, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 17, 2012
[Trigger point therapy for myofascial pain in cancer patients (second report) analysis results of special use-results surveillance by neovitacain® injection]
Asami Yamaguchi, Yoshio Ogino, Chie Iwakoshi, et al.
Journal of Pharmacological Sciences
|
April 23, 2011
Selective M3 muscarinic receptor antagonist inhibits small-cell lung carcinoma growth in a mouse orthotopic xenograft model
Nozomi Ami, Kazumi Koga, Hiroshi Fushiki, et al.
Chemical & Pharmaceutical Bulletin
|
April 2, 2005
Discovery of 2-aminothiazole-4-carboxamides, a novel class of muscarinic M(3) selective antagonists, through solution-phase parallel synthesis
Yufu Sagara, Morihiro Mitsuya, Minaho Uchiyama, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 12, 2003
Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2
Yoshio Ogino, Norikazu Ohtake, Kensuke Kobayashi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 6, 2018
TAS05567, a Novel Potent and Selective Spleen Tyrosine Kinase Inhibitor, Abrogates Immunoglobulin-Mediated Autoimmune and Allergic Reactions in Rodent Models
Hiroaki Hayashi, Ryusuke Kaneko, Shunsuke Demizu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
December 27, 2012
[Two cases of interstitial pneumonia caused by cetuximab plus mFOLFOX6 therapy in metastatic colorectal cancer patients]
Masanobu Shioiri, Makoto Hasegawa, Hiroaki Tanaka, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
March 8, 2005
Pituitary abscess in a patient with painless thyroiditis
Akira Matsuno, Yoshio Ogino, Haruko Katayama, et al.
Expert Opinion on Therapeutic Patents
|
September 12, 2009
Modulation of neuropeptide Y receptors for the treatment of obesity
Nagaaki Sato, Yoshio Ogino, Satoshi Mashiko, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
October 15, 2011
[Trigger point therapy for myofascial pain in cancer patients (first report)-analysis results of special use-results surveillance by Neovitacain® injection-]
Asami Yamaguchi, Yoshio Ogino, Chie Iwakoshi, et al.
Case Reports in Obstetrics and Gynecology
|
September 4, 2014
An Unusual Case of Fulminant Type 1 Diabetes during the Second Trimester of Pregnancy
Tomohiro Okuda, Sadao Yamashita, Yoshio Ogino, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 17, 2012
[Trigger point therapy for myofascial pain in cancer patients (second report) analysis results of special use-results surveillance by neovitacain® injection]
Asami Yamaguchi, Yoshio Ogino, Chie Iwakoshi, et al.
Journal of Pharmacological Sciences
|
April 23, 2011
Selective M3 muscarinic receptor antagonist inhibits small-cell lung carcinoma growth in a mouse orthotopic xenograft model
Nozomi Ami, Kazumi Koga, Hiroshi Fushiki, et al.
Chemical & Pharmaceutical Bulletin
|
April 2, 2005
Discovery of 2-aminothiazole-4-carboxamides, a novel class of muscarinic M(3) selective antagonists, through solution-phase parallel synthesis
Yufu Sagara, Morihiro Mitsuya, Minaho Uchiyama, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 12, 2003
Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2
Yoshio Ogino, Norikazu Ohtake, Kensuke Kobayashi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 6, 2018
TAS05567, a Novel Potent and Selective Spleen Tyrosine Kinase Inhibitor, Abrogates Immunoglobulin-Mediated Autoimmune and Allergic Reactions in Rodent Models
Hiroaki Hayashi, Ryusuke Kaneko, Shunsuke Demizu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
December 27, 2012
[Two cases of interstitial pneumonia caused by cetuximab plus mFOLFOX6 therapy in metastatic colorectal cancer patients]
Masanobu Shioiri, Makoto Hasegawa, Hiroaki Tanaka, et al.
Page
of 2